Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Oct;65(4):460–466. doi: 10.1136/jnnp.65.4.460

Quality of life in multiple sclerosis in France, Germany, and the United Kingdom

N Murphy, C Confavreux, J Haas, N Konig, E Roullet, M Sailer, M Swash, C Young, M J-L
PMCID: PMC2170316  PMID: 9771766

Abstract

OBJECTIVE—To assess the quality of life (QoL) of patients with multiple sclerosis in France, Germany, and the United Kingdom with a cross sectional study.
METHODS—Patients were classified into three severity groups according to the expanded disability severity scale (EDSS); stage I, II, and III, corresponding to mild (EDSS 1.0-3.5), moderate (EDSS 4.0-6.0), or severe (EDSS 6.5-8.0) multiple sclerosis respectively. Ninety patients with multiple sclerosis and 30 control patients without multiple sclerosis were recruited in each country. Control patients were matched to the patients with multiple sclerosis according to age and sex. Quality of life was assessed using the functional status questionnaire (FSQ).
RESULTS—The aspects of QoL that were mostly affected in the three countries under study were physical function and general wellbeing. Social role function decreased with increased severity of disease in France and in particular in Germany. Multiple sclerosis did not seem to have an impact on psychological function. The QoL of control patients was systematically higher than that of patients with multiple sclerosis.
CONCLUSIONS—Use of such a generic scale showed that progression of multiple sclerosis is accompanied by a decrease in QoL and suggested that this could be a relevant measurement in assessing the effect of treatment and progression of disease. Variation between countries, however, may be important.



Full Text

The Full Text of this article is available as a PDF (162.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gerhart K. A., Koziol-McLain J., Lowenstein S. R., Whiteneck G. G. Quality of life following spinal cord injury: knowledge and attitudes of emergency care providers. Ann Emerg Med. 1994 Apr;23(4):807–812. doi: 10.1016/s0196-0644(94)70318-3. [DOI] [PubMed] [Google Scholar]
  2. Hyman M. D. Social psychological factors affecting disability among ambulatory patients. J Chronic Dis. 1975 Apr;28(4):199–216. doi: 10.1016/0021-9681(75)90051-x. [DOI] [PubMed] [Google Scholar]
  3. Jette A. M., Davies A. R., Cleary P. D., Calkins D. R., Rubenstein L. V., Fink A., Kosecoff J., Young R. T., Brook R. H., Delbanco T. L. The Functional Status Questionnaire: reliability and validity when used in primary care. J Gen Intern Med. 1986 May-Jun;1(3):143–149. doi: 10.1007/BF02602324. [DOI] [PubMed] [Google Scholar]
  4. Murray T. J. The psychosocial aspects of multiple sclerosis. Neurol Clin. 1995 Feb;13(1):197–223. [PubMed] [Google Scholar]
  5. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  6. Rao S. M., Leo G. J., Ellington L., Nauertz T., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 1991 May;41(5):692–696. doi: 10.1212/wnl.41.5.692. [DOI] [PubMed] [Google Scholar]
  7. Rothwell P. M., McDowell Z., Wong C. K., Dorman P. J. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997 May 31;314(7094):1580–1583. doi: 10.1136/bmj.314.7094.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rudick R. A., Miller D., Clough J. D., Gragg L. A., Farmer R. G. Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol. 1992 Dec;49(12):1237–1242. doi: 10.1001/archneur.1992.00530360035014. [DOI] [PubMed] [Google Scholar]
  9. Slevin M. L., Plant H., Lynch D., Drinkwater J., Gregory W. M. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988 Jan;57(1):109–112. doi: 10.1038/bjc.1988.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Staquet M., Berzon R., Osoba D., Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res. 1996 Oct;5(5):496–502. doi: 10.1007/BF00540022. [DOI] [PubMed] [Google Scholar]
  11. Torrance G. W. Measurement of health state utilities for economic appraisal. J Health Econ. 1986 Mar;5(1):1–30. doi: 10.1016/0167-6296(86)90020-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES